Small airway disease and asthma control

References

• Global Initiative for Asthma. Global strategy for asthma management and prevention, 2019. Available: https://ginasthma.org/gina-reports/.
   Google Scholar
• Sekerel BE, Gemicioglu B, Soriano JB. Asthma insights and reality in Turkey (AIRET) study. Respir Med. 2006;100(10):1850–1854. doi:10.1016/j.rmed.2006.01.024.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE, GOAL Investigators Group Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170(8):836–844. doi:10.1164/rccm.200401-033OC.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802–807. doi:10.1183/09031936.00.16580200.
   PubMed Web of Science ®Google Scholar
• Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and Link to Symptoms and Experience (REALISE) survey. Prim Care Respir Med. 2014;24:140–149.
   Web of Science ®Google Scholar
• Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H, LIAISON Study Group Determinants and impact of suboptimal asthma control in Europe: The international cross-sectional and longitudinal assessment on asthma control (LIAISON) study. Respir Res. 2016;17(1):51. doi:10.1186/s12931-016-0374-z.
   PubMed Web of Science ®Google Scholar
• Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1.doi:10.1186/s40733-016-0029-3.
   PubMedGoogle Scholar
• Lingner H, Ernst S, Groβhennig A, Djahangiri N, Scheub D, Wittmann M, Schultz K. Asthma control and health-related quality of life one year after inpatient pulmonary rehabilitation: the ProKAR study. J Asthma. 2015;52(6):614–621. doi:10.3109/02770903.2014.996650.
   PubMed Web of Science ®Google Scholar
• Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med. 2008;102(12):1681–1693. doi:10.1016/j.rmed.2008.08.003.
   PubMed Web of Science ®Google Scholar
• Lavorini F, Usmani OS. Correct inhalation technique is critical in achieving good asthma control. Prim Care Respir J. 2013;22(4):383–392.
   PubMedGoogle Scholar
• Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33(4):897–906. doi:10.1183/09031936.00121308.
   PubMed Web of Science ®Google Scholar
• Kuyper LM, Paré PD, Hogg JC, Lambert RK, Ionescu D, Woods R, Bai TR. Characterization of airway plugging in fatal asthma. Am J Med. 2003;115(1):6–11. doi:10.1016/s0002-9343(03)00241-9.
   PubMed Web of Science ®Google Scholar
• Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol. 1997;100(1):44–51. doi:10.1016/s0091-6749(97)70193-3.
   PubMed Web of Science ®Google Scholar
• Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, et al. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an interasma (Global Asthma Association—GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN). Asthma Res Pract. 2016;2:12.
   PubMedGoogle Scholar
• Mead J. The lung’s “quiet zone. N Engl J Med. 1970;282(23):1318–1319. doi:10.1056/NEJM197006042822311.
   PubMedGoogle Scholar
• Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev. 2011;20(119):23–33.
   PubMedGoogle Scholar
• Postma DS, Brightling C, Baldi S, Van den Berge M, Fabbri LM, Gagnatelli A, Papi A, Van der Molen T, Rabe KF, Siddiqui S, ATLANTIS study group, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7(5):402–416. doi:10.1016/S2213-2600(19)30049-9.
   PubMed Web of Science ®Google Scholar
• Cottini M, Licini A, Lombardi C, Berti A. Clinical characterization and predictors of IOS-defined small-airway dysfunction in asthma. J Allergy Clin Immunol Pract. 2020;8(3):997–1004.e2. doi:10.1016/j.jaip.2019.10.040.
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Brand PL, de Jong PM, Koeter GH, Postma DS. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. Thorax. 1994;49(11):1109–1115. doi:10.1136/thx.49.11.1109.
   PubMed Web of Science ®Google Scholar
• Lipworth B, Manoharan A, Anderson W. Unlocking the quiet zone: the small airway asthma phenotype. Lancet Respir Med. 2014;2(6):497–506. doi:10.1016/S2213-2600(14)70103-1.
   PubMed Web of Science ®Google Scholar
• Santus P, Radovanovic D, Pecchiari M, Ferrando M, Tursi F, Patella V, Braido F. The relevance of targeting treatment to small airways in asthma and COPD. Respir Care. 2020;65(9):1392–1412. doi:10.4187/respcare.07237.
   PubMed Web of Science ®Google Scholar
• Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF, Szefler SJ, Taussig L, Bacharier LB, Morgan W, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol. 2010;126(3):527–534. doi:10.1016/j.jaci.2010.05.016.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051–1058. doi:10.1183/09031936.00128113.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, ATS/ERS Task Force, et al. Standardization of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• Uysal MA, Mungan D, Yorgancioglu A, Yildiz F, Akgun M, Gemicioglu B, Turktas H, Study Group, Turkish Asthma Control Test (TACT), Turkey Asthma control test via text messaging: could it be a tool for evaluating asthma control? J Asthma. 2013;50(10):1083–1089. doi:10.3109/02770903.2013.832294.
   PubMed Web of Science ®Google Scholar
• Usmani OS, Singh D, Spinola M, Bizzi A, Barnes PJ. The prevalence of small airways disease in adult asthma: a systematic literature review. Respir Med. 2016;116:19–27. doi:10.1016/j.rmed.2016.05.006.
   PubMed Web of Science ®Google Scholar
• Scichilone N, Battaglia S, Olivieri D, Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond? Allergy. 2009;64(11):1563–1569. doi:10.1111/j.1398-9995.2009.02139.x.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Zamel N. Simplified diagnosis of small-airway obstruction. N Engl J Med. 1973;288(8):395–398. doi:10.1056/NEJM197302222880805.
   PubMed Web of Science ®Google Scholar
• Siroux V, Boudier A, Dolgopoloff M, Chanoine S, Bousquet J, Gormand F, Just J, Le Moual N, Nadif R, Pison C, et al. Forced mid-expiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes. J Allergy Clin Immunol. 2016;137(6):1709–1716.e6. doi:10.1016/j.jaci.2015.10.029.
   PubMed Web of Science ®Google Scholar
• Riley CM, Wenzel SE, Castro M, Erzurum SC, Chung KF, Fitzpatrick AM, Gaston B, Israel E, Moore WC, Bleecker ER, et al. Clinical implications of having reduced mid forced expiratory flow rates (FEF25–75), independently of FEV1, adult patients with asthma. PLoS One. 2015; 10(12):e0145476. doi:10.1371/journal.pone.0145476.
   Web of Science ®Google Scholar
• Sutherland ER, Martin RJ, Bowler RP, Zhang Y, Rex MD, Kraft M. Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol. 2004;113(6):1046–1050. doi:10.1016/j.jaci.2004.03.016.
   PubMed Web of Science ®Google Scholar
• Hamid Q. Pathogenesis of small airways in asthma. Respiration. 2012;84(1):4–11. doi:10.1159/000339550.
   PubMed Web of Science ®Google Scholar
• Doeing DC, Solway J. Airway smooth muscle in the pathophysiology and treatment of asthma. J Appl Physiol (1985). 2013;114(7):834–843. doi:10.1152/japplphysiol.00950.2012.
   PubMed Web of Science ®Google Scholar
• Qin R, An J, Xie J, Huang R, Xie Y, He L, Xv H, Qian G, Li J. FEF25–75% is a more sensitive measure reflecting airway dysfunction in patients with Asthma: A comparison study using FEF25–75% and FEV1. J Allergy Clin Immunol Pract. 2021;9(10):3649–3659.e6. doi:10.1016/j.jaip.2021.06.027.
   PubMed Web of Science ®Google Scholar
• van der Wiel E, Ten HN, Postma DS, van den Berge M. Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. J Allergy Clin Immunol. 2013;131(3):646–657. doi:10.1016/j.jaci.2012.12.1567.
   PubMed Web of Science ®Google Scholar